Bausch Health Companies (BHC) Financials

$5.75

$0.10 (1.68%)

As on 25-Sep-2026 13:43EDT

Market cap

$2,121 Mln

Revenue (TTM)

$10,853 Mln

P/E Ratio

--

P/B Ratio

18.8

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	1,400.00	1,597.00	1,032.00	-728.00	1,426.00
Cash Flow from Investing Activities	--	-595.00	-454.00	-2,145.00	-303.00	409.00
Cash from Financing Activities	--	-742.00	-868.00	1,475.00	-474.00	-1,513.00
Net Cash Inflow / Outflow	--	--	--	--	-1,505.00	322.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.96	0.42	-0.12	-1.62	-0.62	-2.60
Cash EPS ($)	--	3.68	3.28	1.84	2.74	1.17
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	3.78	4.29	2.83	-2.01	3.92
Free Cash Flow per Share ($)	--	2.71	3.39	2.08	-2.75	3.14

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	0.76	-0.22	-2.86	-1.05	-4.01
ROE (%)	--	-17.14	4.00	69.08	61.98	-332.05
ROA (%)	-3.57	0.59	-0.17	-2.23	-0.82	-3.14
EBIT Margin (%)	8.06	19.20	19.40	18.51	18.27	20.25
Net Margin (%)	-10.12	1.53	-0.48	-6.76	-2.50	-11.30
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	10.09	0.07	0.10	0.08	-0.04	0.05
EBIT Growth (%)	-56.81	5.57	15.18	9.23	-13.11	30.08
Net Profit Growth (%)	-845.27	441.30	92.23	-163.11	76.27	-69.59
EPS Growth (%)	-1,242.86	4.43	0.92	-1.61	0.76	-0.67
Book Value Growth (%)	-128.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	16.40	-65.18	-4.95	-10.10	-10.60
Price / Book Value	18.78	-4.66	-2.34	-2.87	-3.28	-295.67
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	10.29	7.07	7.54	8.45	7.81	9.87
Close Price ($)	4.93	6.95	8.06	8.02	6.28	27.61
High Price ($)	8.69	8.69	11.46	10.23	28.08	34.80
Low Price ($)	4.57	4.25	3.96	5.57	4.00	20.92
Market Cap ($ Cr)	2,120.53	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-11.22	-38.35	-17.06	-21.91	-30.01	-667.76
Short term debt to equity ratio	-0.50	-0.54	-2.14	-0.44	-0.62	-1.47
Current Ratio	1.44	1.47	0.86	1.30	1.08	1.08
Quick Ratio	1.08	1.08	0.62	0.94	0.80	0.89
Interest Coverage	0.54	1.23	1.35	1.22	1.01	1.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	20.85	22.86	22.23	22.82	22.03	21.05
Asset Turnover	0.35	0.39	0.36	0.33	0.30	0.28
Receivable days	--	79.82	78.51	79.00	80.14	72.58
Inventory Days	--	195.23	206.06	187.98	160.92	159.21
Payable days	--	76.06	90.26	88.49	71.69	56.76
Cash Conversion Cycle	--	198.99	194.31	178.48	169.37	175.03

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.